INGN חוב כולל להון Inogen Inc

This chart illustrating the price evolution of the stock shows the separate_debt_total_eq metric at 0.09. The stability of Inogen, Inc. (INGN) metrics is driven by steady, economy-independent demand for medical technology treating chronic pathologies. The business is currently expanding into global markets and the home care sector due to market saturation in the US. The company's leadership in oxygen concentrator production is supported by a robust patent portfolio and insurance systems.

For a long-term investor, assessing the financial stability of Inogen, Inc. (INGN) begins with an analysis of the debt load. This ratio determines the proportion of borrowed funds relative to equity, measuring the risk of insolvency. The trend in the debt-to-equity ratio demonstrates the balance sheet's dependence on external financing. Amid intense price competition in the oxygen concentrator market, moderate debt is critical for maintaining margins. A stable metric confirms the company's ability to develop its brand without critical bankruptcy risks.